Pentixapharm Holding Ag (PTP.D.IX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 23,232 | 9,701 | 1,086 | 2,387 |
| Marketable Securities | N/A | 531 | N/A | N/A |
| Other current assets | 8,049 | 8,479 | 2,766 | 171 |
| TOTAL | $31,281 | $18,711 | $3,852 | $2,558 |
| Non-Current Assets | ||||
| PPE Net | 269 | 324 | 333 | 264 |
| Intangibles | 35,354 | 52,565 | 47,888 | 25,003 |
| Other Non-Current Assets | 484 | 1,798 | 1,803 | 1,321 |
| TOTAL | $36,107 | $54,687 | $50,024 | $26,588 |
| Total Assets | $67,388 | $73,398 | $53,876 | $29,146 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,943 | 2,542 | 207 | 399 |
| Other current liabilities | 210 | 6,795 | 1,629 | 103 |
| TOTAL | $14,041 | $9,397 | $1,842 | $502 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 2 | 6,643 | 6,116 | 0 |
| TOTAL | $3,932 | $15,520 | $13,568 | $762 |
| Total Liabilities | $17,973 | $24,917 | $15,410 | $1,264 |
| Shareholders' Equity | ||||
| Common Shares | 24,795 | 21,700 | 89 | 89 |
| Retained earnings | -12,843 | 2,129 | -298 | -4,453 |
| TOTAL | $49,415 | $48,481 | $38,466 | $27,882 |
| Total Liabilities And Equity | $67,388 | $73,398 | $53,876 | $29,146 |